Dana Farber Cancer Institute- Chestnut Hill

Clinical research site in Newton, Massachusetts · Dana-Farber Cancer Institute – Chestnut Hill, 300 Boylston St, Chestnut Hill, MA 02467 · (617) 632-3000 · Website

Part of Dana-Farber Cancer Institute

As of July 2026, 6 paid clinical trials are recruiting at Dana Farber Cancer Institute- Chestnut Hill in Newton, Massachusetts. Active studies at this site cover conditions such as Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma and Gastroesophageal Junction Adenocarcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Dana Farber Cancer Institute- Chestnut Hill (6)

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for Carcinoma, Renal Cell

109 locations incl. Phoenix

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for Intestinal Neoplasms

166 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for Carcinoma, Non-Small Cell Lung

104 locations incl. Anchorage

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04389632·Phase 1·Recruiting·Listed May 2020

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

for Melanoma

31 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 16+

Code: NCT05355701·Phase 1·Recruiting·Listed May 2022

Apply to this trial

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

for Multiple Myeloma

34 locations incl. Coral Gables

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06215118·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for Advanced/Metastatic Solid Tumors

21 locations incl. Duarte

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07090499·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

More research sites in Newton

Boston Center for Memory (8 trials)
Dana-Farber Cancer Institute - Chestnut Hill (5 trials)
Alkermes Investigational Site (2 trials)
Newton Wellesley Hospital (2 trials)
Brigham & Women's Hospital (1 trial)
Dana Farber Cancer Institute (1 trial)
Dana-Farber Cancer Institute -Chestnut Hill (1 trial)
Dynocardia Inc (1 trial)
Mass General Cancer Center Newton-Wellesley Hospital (1 trial)
Mass General Cancer Center at Newton-Wellesley Hospital's Vernon Cancer Center (1 trial)

Explore more

Paid clinical trials in Newton, MA · Massachusetts clinical trials